![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
National Human Genome Research Institute (NHGRI) |
---|---|
Information provided by: | National Institutes of Health Clinical Center (CC) |
ClinicalTrials.gov Identifier: | NCT00766571 |
This study will explore the medical problems in patients with VACTERL association and identify gene changes that might be responsible for them. VACTERL association can affect many parts of the body, including the bones of the spine, the heart, the lower intestinal tract, the connection between the trachea and esophagus, the kidneys and the arms. Information from this study may lead to a better understanding of the disease and improved treatment and genetic counseling.
Patients with VACTERL association and their parents and siblings may be eligible for this study.
Patients are admitted to the NIH Clinical Center for evaluation over 3 to 4 days that may include the following procedures:
Parents of patients have the following procedures:
Siblings of patients have the following procedures:
Condition |
---|
Congenital Abnormalities Birth Defects Congenital Defects |
Study Type: | Observational |
Official Title: | Clinical and Genetic Studies of VACTERL Association |
Estimated Enrollment: | 500 |
Study Start Date: | September 2008 |
Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |
The combination of vertebral defects, anal atresia, cardiac anomalies, tracheo-esophageal fistula, radial dysplasia and limb anomalies, and renal anomalies, termed VACTERL association, has been used as a clinical descriptor for a specific group of phenotypic manifestations that have been observed to occur together.
Depending upon the diagnostic criteria used, the prevalence may be as high as 1 in 6000 live births. VACTERL association is felt to be due to defects in early embryogenesis, and is likely to be genetically heterogeneous.
The purpose of the present study is to increase the understanding of the clinical manifestations and genetic causes of VACTERL association through detailed physical, laboratory, and radiological studies. We also plan to examine the spectrum of clinical characteristics in VACTERL association to facilitate early diagnosis and clinical management, including genetic counseling. To accomplish this, we plan to enroll approximately 10-20 affected individuals along with their family members for a total of 30-60 total individuals each year, with an enrollment ceiling of 150 total individuals (affected individuals plus relatives). Patients and their families will be seen at the NIH clinical center.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
(A) For affected individuals, determination of clinical criteria for inclusion will be determined by prior medical record review before participation. Inclusion criteria may be met in 1 of 3 ways:
(B) First degree relatives (parents and/or siblings of affected individuals) of patients with VACTERL association are also eligible to participate in portions of the protocol even if they have no features of VACTERL association.
EXCLUSION CRITERIA:
Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
Contact: TTY | 1-866-411-1010 |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
Bethesda, Maryland, United States, 20892 |
Study ID Numbers: | 080224, 08-HG-0224 |
Study First Received: | October 3, 2008 |
Last Updated: | August 24, 2009 |
ClinicalTrials.gov Identifier: | NCT00766571 History of Changes |
Health Authority: | United States: Federal Government |
VACTERL Association VATER Association Multiple Congenital Anomalies VACTERL |
Congenital Defects Birth Defects Congenital Abnormalities |
VACTERL Association Abnormalities, Multiple Congenital Abnormalities |
Congenital Abnormalities |